FFG
APYX icon

Frisch Financial Group’s Apyx Medical APYX Stock Holding History

Frisch Financial Group’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,431
Closed -$52K – 116
2023
Q2 		$52K Hold
10,431
– – 0.02% 112
2023
Q1 		$30K Hold
10,431
– – 0.01% 113
2022
Q4 		$24K Hold
10,431
– – 0.01% 131
2022
Q3 		$47K Hold
10,431
– – 0.02% 119
2022
Q2 		$61K Hold
10,431
– – 0.02% 121
2022
Q1 		$68K Hold
10,431
– – 0.02% 140
2021
Q4 		$134K Sell
10,431
-2,227
-18% -$31.2K 0.04% 152
2021
Q3 		$175K Hold
12,658
– – 0.06% 145
2021
Q2 		$131K Hold
12,658
– – 0.04% 150
2021
Q1 		$122K Sell
12,658
-2,500
-16% -$25K 0.04% 148
2020
Q4 		$109K Sell
15,158
-2,500
-14% -$16.6K 0.04% 135
2020
Q3 		$83K Hold
17,658
– – 0.04% 104
2020
Q2 		$98K Hold
17,658
– – 0.05% 94
2020
Q1 		$63K Hold
17,658
– – 0.04% 103
2019
Q4 		$149K Hold
17,658
– – 0.07% 113
2019
Q3 		$120K Buy
17,658
+4,248
+32% +$30.1K 0.07% 99
2019
Q2 		$90K Sell
13,410
-4,248
-24% -$23.1K 0.06% 98
2019
Q1 		$111K Sell
17,658
-7,150
-29% -$55.3K 0.07% 104
2018
Q4 		$161K Buy
+24,808
New +$150K 0.11% 94

Other funds holding APYX

ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Frisch Financial Group's APYX Position: Q3 2023 in Review

Frisch Financial Group sold out of Apyx Medical (APYX) in Q3 2023, closing a stake of 10,431 shares — an estimated $52K sold.

Frisch Financial Group first reported a position in APYX in Q4 2018 and held it in 19 quarters. The position peaked at $175K in Q3 2021. 62 funds tracked by Wall St. Rank hold APYX as of Q3 2023.

  • Frisch Financial Group reported no remaining Apyx Medical position as of Q3 2023 after selling out during the quarter.
  • Frisch Financial Group sold 10,431 Apyx Medical shares in Q3 2023, an estimated $52K.
  • Frisch Financial Group first reported a position in Apyx Medical in Q4 2018 and held it in 19 quarters.
  • Frisch Financial Group's Apyx Medical position peaked at $175K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2023.

Based on Frisch Financial Group's 13F filing for Q3 2023, filed 14 Nov 2023.